文献速递腹部MR

异常胰胆管汇合处的临床影像学特征

Clinico-radiological attributes of abnormal pancreaticobiliary junction.
PubMed 文献 · Abdom Radiol (NY) · 2025-04-03

回顾性筛查18个月内13482例MRCP检查,异常胰胆管汇合处(APBJ)检出率为0.5%(67例),其中77%合并胆总管囊肿(CDC);无APBJ者CDC仅0.85%(P<0.0001)。APBJ无胆管扩张亚组胆道恶性肿瘤风险为CDC组的13.8倍(26.7% vs 1.9%,P=0.008)。

要点

  • MRCP上十二指肠壁外任何长度的共同通道均应判为APBJ,其长度与并发症无统计学相关。
  • APBJ合并CDC以Todani I型最多见(86%),其次为IV型(14%)。
  • APBJ无胆管扩张亚组胆道恶性肿瘤风险显著高于CDC组(OR 13.8)。

核心结论

  • 十二指肠壁外任何长度的共同胰胆管通道均须考虑为APBJ,共同通道实际长度与其并发症发生无相关性;APBJ无胆管扩张亚组发生胆道恶性肿瘤的可能性是CDC组的13.8倍,作者建议转变监测策略并对APBJ患者常规筛查胆道恶性肿瘤(即使无CDC),或可考虑预防性胆囊切除术。

研究设计与样本

  • 回顾性筛查本院放射科18个月内全部MRCP检查(n=13482),记录APBJ(十二指肠壁外任何长度共同通道)与CDC的存在及类型、其他共存胰胆管异常及并发症。

关键影像表现/征象

  • APBJ检出率为0.5%(67例),其中77%(52/67)合并CDC。
  • 无APBJ患者中CDC仅占0.85%(P<0.0001)。
  • APBJ合并CDC以Todani I型最多见(86%),其次为IV型(14%)。
  • CDC患者中31%合并APBJ(52/165),多数CDC患者(69%)无APBJ。

诊断标准与关键数值

  • APBJ定义为十二指肠壁外任何长度的共同通道,不设长度阈值。
  • APBJ合并CDC亚组(n=52)vs APBJ无CDC亚组(n=15):年龄25岁 vs 40岁(P=0.003)。
  • 共同通道长度14.4±6 mm vs 10.6±5 mm(P=0.03)。
  • 胆道恶性肿瘤风险1.9% vs 26.7%(P=0.008,OR 13.8)。

临床应用与阅片要点

  • MRCP阅片时对十二指肠壁外任何长度共同通道均应判为APBJ,不因通道短而忽略。
  • APBJ无胆管扩张者并发症风险更高,作者建议对APBJ患者常规筛查胆道恶性肿瘤,即使无CDC。
  • 作者提出或可对APBJ患者行预防性胆囊切除术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: To evaluate the prevalence of abnormal pancreaticobiliary junction (APBJ) on Magnetic Resonance Cholangio-Pancreatography (MRCP) in patients with and without choledochal cyst (CDC), and study their clinico-radiological profile.

METHODS: We have retrospectively screened all MRCP studies (n = 13,482) done in our Radiology department over 18 months and documented the presence and type of APBJ (any length of extra-duodenal common channel) and CDC, other co-existing pancreaticobiliary abnormalities including complications.

RESULTS: Prevalence of APBJ was 0.5% (n = 67) with 77% of them showing CDC (52/67) while only 0.85% of patients without APBJ have CDC (p value < 0.0001). The most common type of CDC associated with APBJ was Todani Type I (86%) followed by type IV (14%). 31% of CDC patients had APBJ (52 out of 165) while the majority of patients with CDC (69%) did not have APBJ. Between the CDC (n = 52) and non-CDC (n = 15) subgroups of APBJ, there was statistically significant difference in the age (25 vs. 40 years, p value 0.003), gender, length of common channel (14.4 ± 6 mm vs. 10.6 ± 5 mm, p value 0.03), JSPBM type of APBJ and the risk of biliary malignancy (1.9% vs. 26.7%, p value 0.008, Odds ratio 13.8). Although idiopathic pancreatitis was also more common in the non-CDC subgroup, this difference was not statistically significant. There was no statistical correlation between the length of common channel and occurrence of CDC, biliary calculi, malignancy or pancreatitis.

CONCLUSION: Any length of common pancreaticobiliary channel outside the duodenal wall must be considered as APBJ; there is no correlation between the actual length of common channel and occurrence of its complications. The often overlooked and underdiagnosed subgroup of APBJ without biliary dilatation are 13.8 times more likely to develop biliary malignancy than the CDC group. We therefore suggest a necessary shift in surveillance strategies and advocate for routine screening of patients with APBJ for any biliary malignancy, even in the absence of CDC, and perhaps subject them to prophylactic cholecystectomy.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Dontheneni SB, Kotha A, Putta T, et al. Clinico-radiological attributes of abnormal pancreaticobiliary junction. Abdom Radiol (NY). 2025. PMID: 40178587. doi:10.1007/s00261-025-04917-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。